Literature DB >> 11485831

B-myb rescues ras-induced premature senescence, which requires its transactivation domain.

H Masselink1, N Vastenhouw, R Bernards.   

Abstract

B-myb, a ubiquitously expressed member of the myb gene family, is highly regulated throughout the cell cycle and appears to be required for cell cycle progression. In contrast to its relatives A-myb, c-myb, and v-myb, no transforming activity of B-myb has been reported thus far. We report here that B-myb can rescue senescence induced by an activated ras oncogene in rodent cells in vitro. We show that transformation by B-Myb involves its ability to activate transcription. Similar to other oncogenic transcription factors, such as c-Myc and E2F, we show that B-Myb also has repression activity. We demonstrate that the C-terminus of B-Myb can function as a repressor of transcription, that B-Myb interacts with the repressor molecules BS69 and N-CoR and that the repression function, like the transactivation domain, contributes to B-myb transformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485831     DOI: 10.1016/s0304-3835(01)00631-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  27 in total

1.  miR-29 and miR-30 regulate B-Myb expression during cellular senescence.

Authors:  Ivan Martinez; Demian Cazalla; Laura L Almstead; Joan A Steitz; Daniel DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis.

Authors:  Lisa Osterloh; Björn von Eyss; Fabienne Schmit; Lena Rein; Denise Hübner; Birgit Samans; Stefanie Hauser; Stefan Gaubatz
Journal:  EMBO J       Date:  2006-12-07       Impact factor: 11.598

3.  Crystal structure of human BS69 Bromo-ZnF-PWWP reveals its role in H3K36me3 nucleosome binding.

Authors:  Juncheng Wang; Su Qin; Fudong Li; Sai Li; Wei Zhang; Junhui Peng; Zhiyong Zhang; Qingguo Gong; Jihui Wu; Yunyu Shi
Journal:  Cell Res       Date:  2014-03-28       Impact factor: 25.617

4.  Downregulation of B-myb promotes senescence via the ROS-mediated p53/p21 pathway, in vascular endothelial cells.

Authors:  Zhihui Zhou; Yanlin Yin; Qun Chang; Guanqun Sun; Jiahui Lin; Yalei Dai
Journal:  Cell Prolif       Date:  2016-11-23       Impact factor: 6.831

5.  MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.

Authors:  Fei Ren; Lisha Wang; Xiaohan Shen; Xiuying Xiao; Zebing Liu; Ping Wei; Yiqin Wang; Peng Qi; Chen Shen; Weiqi Sheng; Xiang Du
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

6.  Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescence.

Authors:  Zhigang Tu; Katherine M Aird; Benjamin G Bitler; Jasmine P Nicodemus; Neil Beeharry; Bing Xia; Tim J Yen; Rugang Zhang
Journal:  Dev Cell       Date:  2011-12-01       Impact factor: 12.270

7.  Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence.

Authors:  Kimberly Johung; Edward C Goodwin; Daniel DiMaio
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

8.  B-Myb promotes S-phase independently of its sequence-specific DNA binding activity and interacts with polymerase delta-interacting protein 1 (Pdip1).

Authors:  Eugen Werwein; Thore Schmedt; Heiko Hoffmann; Clemens Usadel; Nora Obermann; Jeffrey D Singer; Karl-Heinz Klempnauer
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

Review 9.  Oncogene-induced senescence: an essential role for Runx.

Authors:  Anna Kilbey; Anne Terry; Ewan R Cameron; James C Neil
Journal:  Cell Cycle       Date:  2008-05-29       Impact factor: 4.534

10.  BS69 is involved in cellular senescence through the p53-p21Cip1 pathway.

Authors:  Wei Zhang; Ho Man Chan; Yan Gao; Randy Poon; Zhenguo Wu
Journal:  EMBO Rep       Date:  2007-08-24       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.